**Abstract**

Haloperidol was commonly used for schizophrenia patients as D2 receptor antagonist. It has been known that haloperidol-induced cardiac sudden death is serious adverse event for schizophrenia patients. Haloperidol antagonizes not only D2 receptor but also σ~1~-receptor (σ~1~R), and we previously reported that σ~1~R stimulation ameliorates cardiac dysfunction by restoring mitochondrial Ca^2+^ mobilization in transverse aortic constriction (TAC) mice. In the cardiomyocytes, σ~1~R is associated with IP~3~ receptor in the sarcoplasmic reticulum (SR) and promotes mitochondrial Ca^2+^ mobilization from SR. Here we found that haloperidol impairs mitochondrial Ca^2+^ mobilization and promotes cardiac hypertrophy via σ~1~R inactivation in primary cultured cardiomyocytes. The σ~1~R inactivation by haloperidol also aggravated Ang II-induced impaired mitochondrial Ca^2+^ mobilization and ATP production. Inversely, σ~1~R agonist SA4503 ameliorated Ang II-induced impaired mitochondrial Ca^2+^ mobilization and ATP production. Our observations suggest that haloperidol promotes progression of heart failure via impairment of σ~1~R-induced mitochondrial ATP production.
